All In Biotech

Drug Trial Radar · NCT03407482

An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus

A Phase II, Open-Label Extension Study of Patients Previously Enrolled in Study GA30044 to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Patients With Moderate to Severe Active Systemic Lupus Erythematosus

Last checked: Nov 19, 2026Latest source record: Dec 19, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

160

Actual

Start

Jan 9, 2018

Primary completion

Nov 20, 2019

Study completion Nov 20, 2019

Sponsor

Lead sponsor
Genentech, Inc.Roche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Jan 23, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 76 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Phase II, multicenter, open-label extension (OLE) study will evaluate the long-term safety and efficacy of GDC-0853 in participants with systemic lupus erythematosus (SLE) who have completed Study GA30044 (NCT02908100) up to 48 weeks.

Conditions

  • Lupus Erythematosus, Systemic

Interventions

  • GDC-0853Drug

    Participants received GDC-0853 at a dose of 200mg, as per the dosing schedule described above.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Adverse Events (AEs)Time frame: Baseline up until 8 weeks after the last dose of study drug (up to 56 weeks)

Locations

53 sites in 11 countries. Site status is shown where the registry gives one.

  • Valerius Medical Group

    Los Alamitos, California

  • RASF-Clinical Research Center

    Boca Raton, Florida

  • Bay Area Arthritis and Osteoporosis

    Brandon, Florida

  • Clinical Research of West Florida

    Clearwater, Florida

  • Institute of Arthritis Research

    Idaho Falls, Idaho

  • Ochsner Clinic Foundation

    Baton Rouge, Louisiana

  • Shanahan Rheumatology & Immunology, PLLC

    Raleigh, North Carolina

  • Tekton Research Inc

    Austin, Texas

  • Accurate Clinical Research

    Houston, Texas

  • Accurate Clinical Research

    Houston, Texas

  • Arthritis Clinic Of Central Texas

    San Marcos, Texas

  • APRILLUS

    Buenos Aires, Argentina

  • Hospital Italiano de La Plata

    La Plata, Argentina

  • CER San Juan Centro Polivalente de Asistencia e Investigacion Clinica

    San Juan, Argentina

  • Centro Médico Privado de Reumatología

    San Miguel de Tucumán, Argentina

  • CIP - Centro Internacional de Pesquisa

    Goiânia, Goiás, Brazil

  • Centro Mineiro de Pesquisa - CMIP

    Juiz de Fora, Minas Gerais, Brazil

  • Edumed - Educação e Saúde SA

    Curitiba, Paraná, Brazil

  • Centro de Pesquisas em Diabetes - CPD

    Porto Alegre, Rio Grande do Sul, Brazil

  • Clinica de Neoplasias Litoral

    Itajaí, Santa Catarina, Brazil

  • Faculdade de Medicina do ABC - FMABC

    Santo André, São Paulo, Brazil

  • Centro Multidisciplinar de Estudos Clínicos - CEMEC*X*

    Santo André, São Paulo, Brazil

  • Centro de Pesquisas Clinicas; CPCLIN

    São Paulo, São Paulo, Brazil

  • Hospital Abreu Sodré - AACD

    São Paulo, São Paulo, Brazil

  • MHAT Plovdiv

    Plovdiv, Bulgaria

  • Medical Center "Teodora", EOOD

    Rousse, Bulgaria

  • Medical Center Excelsior OOD

    Sofia, Bulgaria

  • UMHAT "Sv. Ivan Rilski", EAD

    Sofia, Bulgaria

  • MC "Synexus - Sofia", EOOD

    Sofia, Bulgaria

  • Medical Center "Nov Rehabilitatsionen Tsentar", EOOD

    Stara Zagora, Bulgaria

  • CTR Estudios SPA

    Providencia, Chile

  • Dermacross

    Santiago, Chile

  • Centro de Estudios Reumatologi

    Santiago, Chile

  • Biomedica

    Santiago, Chile

  • Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS

    Barranquilla, Colombia

  • Centro de Investigacion Medico Asistencial S.A.S

    Barranquilla, Colombia

  • Medicity S.A.S.

    Bucaramanga, Colombia

  • Servimed S.A.S.

    Bucaramanga, Colombia

  • Hospital Pablo Tobon Uribe

    Medellín, Colombia

  • Hospital Angeles Lindavista

    México, Mexico

Showing 40 of 53 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.